عبدالله نادر. “Evaluation of the Efficacy of Bevacizumab in Recurrence Metastatic Ovarian Cancer As a Second-Line and Beyond”. Latakia University Journal -Medical Sciences Series 44, no. 1 (March 29, 2022): 49–57. Accessed July 29, 2025. https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/12000.